University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 5 of 18
Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
NCT04846829
Feasibility of Stimulating the Visual Cortex in Blind
NCT02747589
Spinal Cord Neuromodulation for Spinal Cord Injury
NCT02313194
Advanced Glaucoma Progression Study
NCT01742819
Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)
NCT01527591
GARM II: A Study on the Genetics of Age-related Maculopathy
NCT01115387
Group PACBT for Depression
NCT07566104
Measuring Pelvic Floor Muscle Fitness Before and After Treatment
NCT07605598
Evaluation of Oral THC and CBD in Men and Women
NCT05067387
Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery
NCT07600697
Applying the Intention-Action Framework to Specialty Referrals
NCT07671976
UCLA Magnesium Formulation Athlete Study
NCT07640685
Calming Minds Study
NCT07577401
Effect of Watermelon on Cardiometabolic Health
NCT07006636
Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones
NCT07408076
Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients
NCT07022574
Epileptic Hippocampus in Alzheimer's Disease
NCT05899764
Refining Risk Prediction Models for Older Adults Using Electronic Health Records
NCT06995365
SMART Pilot Trial of Glycemic Screening Outreach
NCT06915194
Effect of Patient Preference for Intraoperative Opioid Use on Early Postoperative Quality of Recovery
NCT06855641
UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
NCT06187519
Pilot Feasibility Trial of HEALthy Beginnings for Middle-Aged, and Older Homeless Women
NCT06743685
Effects of Breathwork and Meditation on Addiction Recovery
NCT07510256
The Effect of Cold Water Immersion on Recovery and Performance in NCAA Division I Athletes
NCT06565468
Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout
NCT06186219
Post-Discharge Follow-up Appointment Scheduling
NCT06387576
Affect Treatment for Depression and Anxiety (TAD Pilot)
NCT06488859
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
NCT06235814
Effects of a Wellbeing Intervention on Inflammation Through Reward and Threat Processes
NCT06294145
UCLA Health Patient Cardiology Care Gaps
NCT06277323
T-UP: Engaging Vulnerable Students in Diabetes Prevention
NCT06385015
Patient Portal Flu Vaccine Reminders (RCT 6)
NCT06062264
Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID
NCT07429903
In Line Aerosol Nebulization With High Flow
NCT05880836
Mechanical Ventilator Weaning in Chronically Ventilated Patients
NCT06976554
Adolescent Acts of Kindness Intervention With Reflection
NCT05267132
Medical Student Firearm Safety Counseling Follow-Up Study
NCT06241937
UCLA Health Patient Health Maintenance Text Reminder July 2023
NCT05979987
Stress & Resilience Study
NCT06063174
Psilocybin-assisted CBT for Depression
NCT05227612
COMP-4 Supplementation and Brachial Artery FMD
NCT05595915
UCLA Health Patient Health Maintenance With Interactive Text Reminder
NCT05791955
Reward Processes and Rehearsal in Exposure Therapy
NCT06132425
Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids
NCT05573906
Feasibility Trial of a Lifestyle Intervention for CHR-P
NCT05532683
Aging and Reward System Response to Inflammation and Anxiety Study
NCT05363527
UCLA Health Patient Health Maintenance Text Reminder
NCT05791942
UCLA Health Patient Health Maintenance Outreach Text Message
NCT05793788
Decreasing Physician Burnout With Professional Coaching
NCT05583435
Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia
NCT05566379
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.